Pharmacology
News
Osteoporosis drugs may extend life after fracture
The study’s findings suggest that bisphosphonates, in particular, have pleiotropic effects beyond the bone.
News
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
Opinion
Hydroxyurea underused in youth with sickle cell anemia
An expert says providers must tell families that their children need to take it every day, no matter the severity of disease.
Conference Coverage
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
News
FDA approves new Merkel cell carcinoma treatment
This marks the first regulatory approval for retifanlimab-dlwr, a PD-1 inhibitor.
News
Tyrosine kinase inhibitors – a new weapon against respiratory viruses?
In vitro and ex vivo data demonstrated NRTKIs’ ability to slow replication of pandemic and seasonal influenza strains
News
FDA expands evinacumab approval to younger kids with HoFH
The agency has okayed evinacumab-dgnb for patients aged 5-11 with homozygous familial hypercholesterolemia.
Conference Coverage
LAA closure device shown safe in groups omitted in trials
New independent studies support safety of left atrial appendage closure devices in broad array of patient types.
News
Liquid albuterol shortage effects reduced by alternative drugs, similar shortages may be increasingly common
The shortage of 0.5% albuterol sulfate inhalation solution gained increased attention earlier this month when Akorn Pharmaceuticals – one of just...
News
New hope for MDS, with AML treatments
Slow progress in treating myelodysplastic syndrome is coming mostly with therapies first developed for acute myeloid leukemia.